ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2021 and some content may be unavailable. To unlock all content for 2021, please visit the archives.

Abstract: PO2110

Boron Exposure and Decreased Risk of Mortality in Kidney Transplant Recipients

Session Information

Category: Transplantation

  • 1902 Transplantation: Clinical

Authors

  • Kremer, Daan, Rijksuniversiteit Groningen, Groningen, Groningen, Netherlands
  • Post, Adrian, Rijksuniversiteit Groningen, Groningen, Groningen, Netherlands
  • Seidel, Ulrike, Christian-Albrechts-Universitat zu Kiel, Kiel, Schleswig-Holstein, Germany
  • van der Veen, Yvonne, Universitair Medisch Centrum Groningen, Groningen, Groningen, Netherlands
  • Groothof, Dion, Rijksuniversiteit Groningen, Groningen, Groningen, Netherlands
  • Gomes Neto, Antonio Wouter, Rijksuniversiteit Groningen, Groningen, Groningen, Netherlands
  • Knobbe, Tim J., Rijksuniversiteit Groningen, Groningen, Groningen, Netherlands
  • Rimbach, Gerald, Christian-Albrechts-Universitat zu Kiel, Kiel, Schleswig-Holstein, Germany
  • Bakker, Stephan J.L., Rijksuniversiteit Groningen, Groningen, Groningen, Netherlands

Group or Team Name

  • TransplantLines Investigators
Background

In a search for potential modifiable factors to improve long-term outcome among kidney transplant recipients (KTR), we studied dietary patterns in the Blue Zones, and hypothesized that boron exposure is associated with improved long-term outcome in KTR.

Methods

We determined 24h urinary boron excretion using inductively coupled plasma mass-spectrometry as a measure of boron intake in 693 stable KTR (57% male, mean age 53y), enrolled in the TransplantLines F&N Biobank and Cohort Study. Dietary intake was assessed using validated food-frequency questionnaires.

Results

Linear regression analyses showed that dietary intake of fruit, wine and nuts were key determinants of boron excretion. In contrast, boron excretion was negatively associated with homocysteine and inflammation parameters. In total, 73 (32%), 47 (20%) and 30 (13%) patients died among the lowest, middle and highest tertiles of boron, respectively (Plog-rank <0.001). Cox regression analyses showed that high boron excretion was strongly associated with lower risk of mortality, independent of age, sex, eGFR and history of cardiovascular disease (HR per doubling: 0.51, 95%CI:0.40 to 0.66, P<0.001, Figure), and other potential clinical and dietary confounders.

Conclusion

Boron may be an overlooked target to improve long-term outcome among KTR and potentially other patients, partly through suggested beneficial effects on inflammation, the methionine-homocysteine cycle, and ageing processes. Interventional trials are warranted to confirm the potential of dietary boron supplementation in KTR and other patient populations.

Associations of urinary boron excretion with risk of all-cause mortality, based on a Cox proportional hazards regression model adjusted for age, sex, eGFR, and history of cardiovascular disease, presented in relation to the histogram of urinary boron excretion.

Funding

  • Clinical Revenue Support